Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2023

22-03-2022 | Diabetic Retinopathy | Original Article

Regular hospital visits and treatment outcomes among people living with type 1 diabetes: a 7-year study from South India

Authors: Arutselvi Devarajan, Satyavani Kumpatla, Vijay Viswanathan

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2023

Login to get access

Abstract

Aim

Literature on how people with type 1 diabetes (TIDM) manage their condition in India is sparse. The aim was to explore the profile, practice of regular visits to the hospital, regular monitoring of glucose and treatment outcomes among people with T1DM.

Methods

A retrospective study was conducted among 239 people with T1DM using electronic medical records at a diabetes specialty care centre in Chennai from 2012 to 2018. Parameters such as socio-demographic, anthropometric and clinical data were collected and categorised into two groups-group 1 (n=141, Regular visit) and group 2 (n=98, Irregular visit).

Results

The median age and duration of diabetes for group 1 and group 2 (age; 19(8,60) and 25(12,50) years, (p<0.001) and duration; 10(2,35) and 8(3,25) years, (p=0.002)) showed significant difference. The median hospital visits were (group 1 vs. group 2; 10.0(7,14) vs. 3(1,9.0) times; p<0.001). No significant difference was seen in HbA1c among the groups. Self-monitoring of blood glucose (SMBG) was high among group 1 (16.3%) compared to group 2 (2%), (p<0.001). The presence of chronic kidney disease (CKD) was found to be high in group 2 (8.2%) than group 1 (0.7%), (p=0.004) and diabetic retinopathy (DR) was also higher among group 2, but did not reach statistical significance (15.3% vs. 9.9%, p=0.147). No gender difference was observed in the presence of complications. None of the individuals who had presence of complications was practicing SMBG regularly.

Conclusion

The individuals who made a minimum of one or more than one hospital visit per year were found to have nil or lesser complications. Individuals who practiced SMBG had less complications compared to those not practicing SMBG.
Literature
3.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diab Care 2013; 36(Suppl 1): S11 –S66. American Diabetes Association. Standards of medical care in diabetes. Diab Care 2013; 36(Suppl 1): S11 –S66.
4.
go back to reference Haller MJ, Satalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr. 2004;144:660–1.CrossRefPubMed Haller MJ, Satalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr. 2004;144:660–1.CrossRefPubMed
5.
go back to reference Virmani A. Type 1 Diabetes in India: the numbers show the way ahead. Indian Pediatr. 2019;56(3):189–90.CrossRefPubMed Virmani A. Type 1 Diabetes in India: the numbers show the way ahead. Indian Pediatr. 2019;56(3):189–90.CrossRefPubMed
6.
go back to reference WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO Documentation Production Services, Geneva. 2006;1-41. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO Documentation Production Services, Geneva. 2006;1-41.
8.
go back to reference Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. (1991). Ophthalmology, 98(5 Suppl), 786–806. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. (1991). Ophthalmology, 98(5 Suppl), 786–806.
9.
go back to reference Amutha A, Kalpana T, Mohan V. Childhood and adolescent onset type 1 diabetes in India. MGM J Med Sci. 2014;1(2):76–83.CrossRef Amutha A, Kalpana T, Mohan V. Childhood and adolescent onset type 1 diabetes in India. MGM J Med Sci. 2014;1(2):76–83.CrossRef
10.
go back to reference Bhatia V, Arya V, Dabadghao P, Balasubramania K, Sharma K, Verghese N, et al. Etiology and outcome of childhood and adolescent diabetes mellitus in North India. J PaediatrEndocrinol Metab. 2004;17:993–9. Bhatia V, Arya V, Dabadghao P, Balasubramania K, Sharma K, Verghese N, et al. Etiology and outcome of childhood and adolescent diabetes mellitus in North India. J PaediatrEndocrinol Metab. 2004;17:993–9.
11.
go back to reference Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J et al., Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111(1):1-9, 1. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J et al., Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111(1):1-9, 1.
12.
go back to reference Moström P, Ahlén E, Imberg H, Hanson PO, Lind M. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diab Res and Care. 2017;5:e000342.CrossRef Moström P, Ahlén E, Imberg H, Hanson PO, Lind M. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diab Res and Care. 2017;5:e000342.CrossRef
13.
go back to reference Wambui Charity K, Kumar AMV, Hinderaker SG, Chinnakali P, Pastakia SD, Kamano J. Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res ClinPract. 2016; 112:37–43. Wambui Charity K, Kumar AMV, Hinderaker SG, Chinnakali P, Pastakia SD, Kamano J. Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res ClinPract. 2016; 112:37–43.
14.
go back to reference Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH. Hirsch IB; T1D Exchange Clinic Network. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diab Care. 2013;36(7):2009–14.CrossRef Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH. Hirsch IB; T1D Exchange Clinic Network. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diab Care. 2013;36(7):2009–14.CrossRef
15.
go back to reference Al Qazaz H, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-NuriR, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33:1028–35. Al Qazaz H, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-NuriR, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33:1028–35.
16.
go back to reference Sudhanshu S, Nair VV, Godbole T, Bhaskar Reddy SV, Bhatia E, Dabadghao P, et al. Glycemic control and longterm complications in paediatric onset type 1 diabetes mellitus: a single-centre experience from Northern India. Indian Paediatr. 2019;56:191–5. Sudhanshu S, Nair VV, Godbole T, Bhaskar Reddy SV, Bhatia E, Dabadghao P, et al. Glycemic control and longterm complications in paediatric onset type 1 diabetes mellitus: a single-centre experience from Northern India. Indian Paediatr. 2019;56:191–5.
17.
go back to reference Mohammad HA, Farghaly HS, Metwalley KA, Monazea EM, Abd El-Hafeez HA. Predictors of glycemic control in children with type 1 diabetes mellitus in Assiut-Egypt. Indian J Endocrinol Metab. 2012;16(5):796–802.CrossRefPubMedPubMedCentral Mohammad HA, Farghaly HS, Metwalley KA, Monazea EM, Abd El-Hafeez HA. Predictors of glycemic control in children with type 1 diabetes mellitus in Assiut-Egypt. Indian J Endocrinol Metab. 2012;16(5):796–802.CrossRefPubMedPubMedCentral
18.
go back to reference Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjörnsdóttir S. Eliasson B; Steering Committee of the Swedish National Diabetes Register. Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diab Care. 2007;30(3):496–502.CrossRef Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjörnsdóttir S. Eliasson B; Steering Committee of the Swedish National Diabetes Register. Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register. Diab Care. 2007;30(3):496–502.CrossRef
19.
go back to reference Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed
Metadata
Title
Regular hospital visits and treatment outcomes among people living with type 1 diabetes: a 7-year study from South India
Authors
Arutselvi Devarajan
Satyavani Kumpatla
Vijay Viswanathan
Publication date
22-03-2022
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2023
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-022-01053-8

Other articles of this Issue 1/2023

International Journal of Diabetes in Developing Countries 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine